Moribe Kunikazu, Tozuka Yuichi, Yamamoto Keiji
Graduate School of Pharmaceutical Sciences, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan.
Adv Drug Deliv Rev. 2008 Feb 14;60(3):328-38. doi: 10.1016/j.addr.2007.03.023. Epub 2007 Oct 5.
Supercritical fluid technique have been exploited in extraction, separation and crystallization processes. In the field of pharmaceutics, supercritical carbon dioxide (scCO(2)) has been used for the purpose of micronization, polymorphic control, and preparation of solid dispersion and complexes. Particle design of active pharmaceutical ingredients is important to make the solid dosage forms with suitable physicochemical properties. Control of the characteristic properties of particles, such as size, shape, crystal structure and morphology is required to optimize the formulation. For solubility enhancement of poorly water-soluble drugs, preparation of the solid dispersion or the complexation with proper drugs or excipients should be a promising approach. This review focuses on aspects of polymorphic control and complexation behavior of active pharmaceutical ingredients by scCO(2) processing.
超临界流体技术已应用于萃取、分离和结晶过程。在制药领域,超临界二氧化碳(scCO₂)已用于药物微粉化、多晶型控制以及固体分散体和络合物的制备。活性药物成分的颗粒设计对于制备具有合适物理化学性质的固体剂型很重要。为了优化制剂,需要控制颗粒的特性,如尺寸、形状、晶体结构和形态。对于提高难溶性药物的溶解度,制备固体分散体或与合适的药物或辅料络合应是一种有前景的方法。本文综述了通过scCO₂处理实现活性药物成分多晶型控制和络合行为的相关方面。